CAS: 1431303-72-8

Iadademstat dihydrochloride (ORY-1001(trans)) , a Potent and Selective Covalent KDM1A/LSD1 Inhibitor, for the Treatment of Acute Leukemia.

Ory-1001(trans) is a protein inhibitor that targets the lysine residues of proteins. It inhibits the growth of cancer cells by binding to the lysine residues on proteins and preventing them from being processed or degraded. This drug has been shown to inhibit the growth of various types of cancer cells in vivo, including cervical cancer, liver cancer, cardiac cancer, and leukemia. Ory-1001(trans) also blocks the activity of various growth factors by inhibiting their transcriptional regulation.

Iadademstat dihydrochloride